Status:
COMPLETED
Hydroxyethyl Starch and Renal Function After Radical Prostatectomy
Lead Sponsor:
Regional Hospital Holstebro
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this project is to investigate if hydroxyethyl starch (HES) is potential nephrotoxic and examine the effects on the circulation and kidneys during administration of HES during surgery.
Detailed Description
Hydroxyethyl starch (HES) is widely used in hospitals to maintain circulation in critically ill patients. In recent years studies have raised suspicion that HES is nephrotoxic. So far acute kidney inj...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Males
- Indication for radical prostatectomy
Exclusion
- Blood donation within the last month
- Lack of wish to participate
- eGFR\< 15ml/min
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01486563
Start Date
January 1 2012
End Date
June 1 2013
Last Update
September 17 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medicinsk forskningsafsnit, Regionshospitalet Holstebro
Holstebro, Denmark, 7500